HUMAN MITOCHONDRIAL GPAT

Details for Australian Patent Application No. 2002318554 (hide)

Owner KISSEI PHARMACEUTICAL CO., LTD.

Inventors SAKAMOTO, Sakae; ONOTA, Hideki; SUGANO, Sumio; NAKAMURA, Yusuke

Pub. Number AU-A-2002318554

PCT Number PCT/JP02/07189

PCT Pub. Number WO2003/008590

Priority 2001-215337 16.07.01 JP

Filing date 16 July 2002

Wipo publication date 3 March 2003

International Classifications

C12N 015/54 Mutation or genetic engineering - Transferases (2)

C12N 009/10 Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 003/10 Drugs for disorders of the metabolism

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 2001-215337 16.07.01 JP

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002318554

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318555-MEDICAL PREPARATION FOR PARENTERAL INJECTION

2002318553-METHOD OF ANALYZING NUCLEIC ACID SPECIFYING GENE SHOWING CHANGE IN EXPRESSION DOSE IN SCHIZOPHRENIA